UK to extend Covid vaccines for children with vulnerable health conditions

The latest decision sets the UK in marked contrast with some other countries such as the US and Canada which have mass vaccinated children aged 12 to 17.

Vaccine
Press Trust of India London
2 min read Last Updated : Jul 20 2021 | 1:25 AM IST

Children over the age of 12 who are at higher risk of getting ill if they catch COVID-19 will be offered a vaccine, Vaccines Minister Nadhim Zahawi told the UK Parliament on Monday.

Based on advice by the UK's Joint Committee on Vaccination and Immunisation (JCVI), the vast majority of children in the UK who are at low risk from the deadly virus will not be offered the vaccine for now.

However, some healthy children over 12 who live with other vulnerable people can have the vaccine, as well as those on the cusp of turning 18. Overall, around 370,000 children will be eligible for a coronavirus vaccine and will be offered the Pfizer/BioNtech jab.

Young people aged 12 to 15 with severe neuro-disabilities, Down's Syndrome, immunosuppression and multiple or severe learning disabilities, as well as people who are household contacts of individuals who are immunosuppressed, will be eligible for vaccination soon, UK Health Secretary Sajid Javid, who is self-isolating after testing positive for COVID-19, said in a statement which was relayed to the House of Commons by Zahawi.

Today's advice does not recommend vaccinating under-18s without underlying health conditions at this point in time. But the JCVI will continue to review new data, and consider whether to recommend vaccinating under-18s without underlying health conditions at a future date, Javid's statement added.

The minister described the COVID-19 vaccines as a wall of defence, which have saved almost 37,000 lives and prevented around 11.7 million infections in England alone.

The latest decision sets the UK in marked contrast with some other countries such as the US and Canada which have mass vaccinated children aged 12 to 17.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusUKCoronavirus TestsCoronavirus Vaccine

First Published: Jul 20 2021 | 1:21 AM IST

Next Story